A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii in Korea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Acinetobacter baumannii is an aerobic Gram-negative coccobacillus that causes nosocomial pneumonia in patients on mechanical ventilation or previously treated with broad-spectrum antibiotics. Nevertheless, community-acquired pneumonia (CAP) caused by A. baumannii, especially multi-drug resistant (MDR) strains, is rare. We experienced the first case of CAP caused by MDR A. baumannii in Korea in a 78-year-old man. This case shows that MDR A. baumannii can cause CAP in Korea.
Abstract
Acinetobacter baumannii is an aerobic Gram-negative coccobacillus that causes nosocomial pneumonia in patients on mechanical ventilation or previously treated with broad-spectrum antibiotics. Nevertheless, community-acquired pneumonia (CAP) caused by A. baumannii, especially multi-drug resistant (MDR) strains, is rare. We experienced the first case of CAP caused by MDR A. baumannii in Korea in a 78-year-old man. This case shows that MDR A. baumannii can cause CAP in Korea.
참고문헌 (18)
- Fournier PE, "The epidemiology and control of Acinetobacter baumannii in health care facilities", Clin Infect Dis, 42, pp.692~699 (2006)
- Towner KJ, "Acinetobacter: an old friend, but a new enemy", J Hosp Infect, 73, pp.355~363 (2009)
- Leung WS, "Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome", Chest, 129, pp.102~109 (2006)
- Papp-Wallace KM, "Carbapenems: past, present, and future", Antimicrob Agents Chemother, 55, pp.4943~4960 (2011)
- Kang SJ, "Epidemiology and clinical features of community-onset Acinetobacter baumannii infections", Infect control Hosp Epidemilo, 33, pp.1053~1055 (2012)
- Falagas ME, "Community- acquired Acinetobacter infections", Eur J Clin Microbiol Infect Dis, 26, pp.857~868 (2007)
- Richet HM, "Building communication networks: international network for the study and prevention of emerging antimicrobial resistance", Emerg Infect Dis, 7, pp.319~322 (2001)
- 이경원, "Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009", Yonsei Medical Journal, 52(5), pp.793~802 (2011), 연세대학교의과대학
- 한상훈, "Acinetobacter baumannii 원인균이 의심되느 지역 사회 획득성 폐렴", Tuberculosis and Respiratory Diseases, 63(3), pp.273~277 (2007), 대한결핵및호흡기학회
- Kang CI, "Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli", Eur J Clin Microbiol Infect Dis, 27, pp.657~661 (2008)
- 나주영, "A Probable Community-Acquired Pneumonia due to Acinetobacter baumannii Infection Presenting the Positive Pneumothorax Test at Autopsy", 대한법의학회지, 34(2), pp.125~128 (2010), 대한법의학회
- 이유미, "균혈증이 동반된 중증 지역사회 획득 Acinetobacter baumannii 폐렴 1예", Infection and Chemotherapy, 44(2), pp.71~74 (2012), 대한감염학회[DOI]
- 오윤정, "A case of fulminant community-acquired Acinetobacter baumannii pneumonia in Korea", The Korean Journal of Internal Medicine, 28(4), pp.486~490 (2013), 대한내과학회[DOI]
- Ong CW, "Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific", Respirology, 14, pp.1200~1205 (2009)
- Anstey NM, "Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia", Clin Infect Dis, 14, pp.83~91 (1992)
- Kempf M, "Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options", Int J Antimicrob Agents, 39, pp.105~114 (2012)
- 이창섭, "Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens", Infection and Chemotherapy, 46(3), pp.149~164 (2014), 대한감염학회
- Zavascki AP, "Combination therapy for carbapenem-resistant Gram-negative bacteria", Expert Rev Anti Infect Ther, 11, pp.1333~1353 (2013)
